W. L. Mcguire, Current status of estrogen receptors in human breast cancer, Cancer, vol.28, issue.S2, pp.638-682, 1975.
DOI : 10.1002/1097-0142(197508)36:2+<638::AID-CNCR2820360805>3.0.CO;2-S

S. Y. Jiang and V. C. Jordan, Growth Regulation of Estrogen Receptor-Negative Breast Cancer Cells Transfected With Complementary DNAs for Estrogen Receptor, JNCI Journal of the National Cancer Institute, vol.84, issue.8, pp.580-91, 1992.
DOI : 10.1093/jnci/84.8.580

A. M. Bamberger, C. Methner, B. W. Lisboa, C. Stadtler, H. M. Schulte et al., Expression pattern of the AP-1 family in breast cancer: Association of fosB expression with a well-differentiated, receptor-positive tumor phenotype, International Journal of Cancer, vol.11, issue.5, pp.533-541, 1999.
DOI : 10.1002/(SICI)1097-0215(19991022)84:5<533::AID-IJC16>3.0.CO;2-J

K. Sugasawa, C. Masutani, A. Uchida, T. Maekawa, P. J. Van-der-spek et al., HHR23B, a human Rad23 homolog, stimulates XPC protein in nucleotide excision repair in vitro., Molecular and Cellular Biology, vol.16, issue.9, pp.4852-61, 1996.
DOI : 10.1128/MCB.16.9.4852

S. Kondo, S. Kubota, T. Shimo, T. Nishida, G. Yosimichi et al., Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases, Carcinogenesis, vol.23, issue.5, pp.769-76, 2002.
DOI : 10.1093/carcin/23.5.769